Connect with us
DAPA Banner

Business

Utz recalls certain Zapp’s and Dirty chips over potential salmonella risk

Published

on

Utz recalls certain Zapp's and Dirty chips over potential salmonella risk

Utz Quality Foods is recalling certain Zapp’s and Dirty brand potato chips that were sold at retail stores nationwide, the Food and Drug Administration said.

The voluntary recall follows a notification to the company that a seasoning containing dry milk powder may contain the presence of salmonella. It was sourced from California Dairies Inc. and supplied by a third party.

Advertisement

The FDA said the affected seasoning batches tested negative for salmonella prior to use, but Utz is recalling the limited varieties of chips out of an abundance of caution. The company is recalling the products based on the ingredient supplier’s recall.

FROZEN PIZZA SOLD AT WALMART, ALDI RECALLED OVER SALMONELLA CONCERNS

No other products produced by Utz Quality Foods are affected, and “We are working in coordination with the U.S. Food and Drug Administration on this recall,” the company told FOX Business in a statement.

Utz has not received any complaints of illness in connection with the recalled products. Customers who have the affected products should not eat them and should discard them.

Advertisement

Utz Quality Foods recalled products:

Zapp’s Brand Bayou Blackened Ranch Potato Chips, 1.5 oz.

Zapp's 1.5-oz. Bayou Blackened Ranch Potato Chips.

Utz Quality Foods is recalling certain Zapp’s 1.5-oz. Bayou Blackened Ranch Potato Chips. (FDA)

  • UPC: 83791272917
  • Batchcodes: 26030070101, 26036070102, 26043070101, 26052070103
  • Best by dates: 8/3/2026, 8/10/2026, 8/17/2026, 8/24/2026

Zapp’s Brand Bayou Blackened Ranch Potato Chips, 2.5 oz.

Zapp's 2.5-oz. Bayou Blackened Ranch Potato Chips.

Utz Quality Foods is recalling certain Zapp’s 2.5-oz. Bayou Blackened Ranch Potato Chips. (FDA / Fox News)

  • UPC: 83791272924
  • Batchcodes: 26029070104, 26044070104, 26045070104, 26058070104
  • Best by dates: 8/3/2026, 8/17/2026, 8/31/2026

RAT POISON FOUND IN BABY FOOD JARS SPARKS CHILLING SCARE, SUSPECT NABBED

Zapp’s Brand Bayou Blackened Ranch Potato Chips, 8 oz.

Zapp's 8-oz. Bayou Blackened Ranch Potato Chips.

Utz Quality Foods is recalling certain Zapp’s 8-oz. Bayou Blackened Ranch Potato Chips. (FDA)

  • UPC: 83791272931
  • Batchcodes: 26024070105, 26024070104, 26029070104, 26030070104, 26037070105, 26038070105, 26044070105, 26045070105
  • Best by dates: 7/27/2026, 8/3/2026, 8/10/2026, 8/17/2026

Dirty Brand Salt and Vinegar Potato Chips, 2 oz.

Dirty salt and vinegar potato chips.

Utz Quality Foods is recalling Dirty brand Salt and Vinegar Potato Chips. (FDA)

  • UPC: 83791520148
  • Batchcodes: 26030070104, 26031070104, 26031070101, 26038070102, 26038070103
  • Best by dates: 8/3/2026, 8/10/2026

GHIRARDELLI RECALLS DRINK MIXES OVER POTENTIAL SALMONELLA CONTAMINATION

Zapp’s Brand Salt and Vinegar Potato Chips, 1.5 oz (60 ct.)

Zapp's Salt and Vinegar Potato Chips.

Utz Quality Foods is recalling certain 1.5-oz. Zapp’s brand Salt and Vinegar Potato Chips. (FDA)

  • UPC: 83791010144
  • Batchcodes: 26030070101, 26031070101, 26036070102, 26037070102
  • Best by dates: 8/3/2026, 8/10/2026

Dirty Brand Maui Onion Potato Chip, 2 oz.

Dirty Maui onion potato chips.

Utz Quality Foods is recalling certain Dirty brand Maui Onion Potato Chips. (FDA)

  • UPC: 83791520162
  • Batchcode: 26052070103
  • Best by date: 8/8/2026

CHOCOLATE SOLD NATIONWIDE RECALLED OVER UNDECLARED ALLERGEN POSING POTENTIAL ‘LIFE-THREATENING’ RISK

Zapp’s Brand Big Cheezy Potato Chip, 2.5 oz.

Zapp's 2.5-oz. Big Cheezy Potato Chips.

Utz Quality Foods is recalling certain Zapp’s brand Big Cheezy Potato Chips. (FDA)

  • UPC: 83791192208
  • Batchcode: 26058070104
  • Best by date: 8/31/2026

Zapp’s Brand Big Cheezy Potato Chip, 8 oz.

Zapp's 8-oz. Big Cheezy Potato Chips.

Utz Quality Foods is recalling certain Zapp’s brand Big Cheezy Potato Chips. (FDA / Fox News)

  • UPC: 83791192246
  • Batchcodes: 26058070104, 26059070104
  • Best by date: 8/31/2026

CLICK HERE TO GET FOX BUSINESS ON THE GO

Dirty Brand Sour Cream and Onion Potato Chips, 2 oz.

Dirty sour cream and onion chips.

Utz Quality Foods is recalling Dirty brand Sour Cream and Onion Potato Chips. (FDA)

  • UPC: 83791520094
  • Batchcode: 26059070104
  • Best by date: 8/31/2026
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Timberwolves Star Running at 3/4 Speed, Returns Faster Than Expected

Published

on

Anthony Edwards

MINNEAPOLIS — Minnesota Timberwolves superstar Anthony Edwards has made remarkable progress in his recovery from a left knee hyperextension and bone bruise, with reports confirming he is now running at about three-quarters speed and has already returned to on-court basketball activities well ahead of initial timelines.

Edwards suffered the injury in Game 4 of the first-round series against the Denver Nuggets in late April. Initial projections called for a multi-week absence, potentially sidelining him for the early portion of the Western Conference semifinals. However, aggressive rehabilitation, including around-the-clock treatment and hyperbaric chamber sessions, has accelerated his return.

As of early May 2026, Edwards has been cleared for full basketball activities and was listed as questionable before Game 1 against the San Antonio Spurs. Multiple reports confirm he participated in pregame warmups and entered the contest off the bench, delivering 18 points in a Timberwolves victory despite playing under a minutes restriction.

Injury Details and Rapid Recovery

Advertisement

The injury involved a hyperextension of the left knee with an accompanying bone bruise. Edwards also manages ongoing right knee soreness described as runner’s knee. Team medical staff initially projected a minimum two-week absence, but Edwards pushed aggressively through rehabilitation protocols.

Timberwolves vice president of medical and performance David Hines noted the timeline was fluid, with Edwards showing “unforeseen progress” in recent days. By early May, he was spotted taking jump shots and performing full-court running at approximately 75% intensity during practice sessions.

Coach Chris Finch confirmed Edwards’ availability for Game 1, describing the decision as a joint one between player, medical staff and coaching. Edwards entered the game in the first quarter and contributed meaningfully despite not being at full strength.

Impact on Timberwolves Playoff Run

Advertisement

Edwards’ quick return provides a significant boost to Minnesota as it faces Victor Wembanyama and the Spurs in the Western Conference semifinals. The Timberwolves advanced past the Nuggets without him in the final two games of the first round, but his presence elevates their championship aspirations.

Even on a minutes restriction, Edwards’ scoring punch and defensive versatility remain critical. His willingness to play through discomfort underscores his competitive drive and importance to the franchise.

Medical and Expert Perspectives

Sports medicine specialists note that bone bruises can vary widely in recovery time. Edwards’ youth, elite athleticism and access to advanced treatments likely contributed to his faster-than-expected progress. However, experts caution against pushing too aggressively, as re-injury risks remain elevated in the playoffs.

Advertisement

The Timberwolves medical team has monitored him closely, using pain management, mobility metrics and functional strength tests to guide clearance. Edwards has communicated optimism to teammates, expressing his desire to contribute as soon as possible.

Fan and Media Reaction

Social media erupted with excitement over Edwards’ return. Clips of his Game 1 performance quickly went viral, with fans praising his toughness. Hashtags related to his recovery and highlights trended as supporters celebrated the star’s resilience.

Analysts highlight Edwards’ history of beating recovery timelines, drawing comparisons to past instances where he returned ahead of schedule. His ability to perform at a high level even while managing bilateral knee issues has drawn admiration across the league.

Advertisement

What’s Next for Edwards

The Timberwolves will continue monitoring Edwards’ workload closely in the series against San Antonio. Expect gradual increases in minutes as he builds confidence and conditioning. Full unrestricted play may take additional games, but his presence alone alters the dynamics of the matchup.

Upcoming updates will focus on how his knee responds to game action and whether any setbacks occur. The organization remains optimistic but cautious, prioritizing long-term health during a deep playoff run.

Edwards’ rapid recovery adds another chapter to his rising superstar narrative. From high draft pick to playoff hero, his toughness and work ethic continue impressing observers. As the Western Conference semifinals unfold, all eyes will remain on the dynamic guard and his ability to perform while managing lingering knee concerns.

Advertisement
Continue Reading

Business

Viavi Solutions: Too Much Data Center Hype, Not Enough Growth In Profitability (VIAV)

Published

on

Viavi Solutions: Too Much Data Center Hype, Not Enough Growth In Profitability (VIAV)

This article was written by

MSc in Finance. Long-term horizon investor mostly with 2-5 year horizon. I like to keep investing simple. I believe a portfolio should consist of a mix of growth, value, and dividend-paying stocks but usually end up looking for value more than anything. I also sell options from time to time.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Ayoh reformulates mayonnaise

Published

on

Ayoh reformulates mayonnaise

Startup switches high-oleic sunflower oil to avocado oil.

Continue Reading

Business

trivago files antitrust damages claim against Google in Germany

Published

on


trivago files antitrust damages claim against Google in Germany

Continue Reading

Business

Lucid plans to adjust production, citing elevated EV inventory

Published

on

Lucid plans to adjust production, citing elevated EV inventory

The LUCID logo is shown at the LA Auto show “AutoMobility LA” in Los Angeles, California, U.S. Nov. 20, 2025.

Mike Blake | Reuters

DETROIT — Lucid Group plans to take actions to better align its production with customer demand for its luxury all-electric vehicles, the company said Tuesday.

Advertisement

The EV manufacturer said it needs to lower its “elevated inventory” of vehicles, which for automakers has historically meant lowering or idling vehicle production.

A company spokesman on Tuesday told CNBC that there is currently no plan to idle its sole U.S. plant in Arizona, but declined to reconfirm the company’s prior production guidance of between 25,000 and 27,000 units.

Lucid, in a release Tuesday, said it will take “further steps to align production with anticipated deliveries and customer demand.” The company did not include the guidance in its release.

The company has produced roughly 3,200 more vehicles than it has sold since 2024, according to its annual production and deliveries. That includes a difference of roughly 2,000 units last year and 2,400 vehicles during the first quarter of 2026.

Advertisement

“We ended the quarter with elevated inventory that we expect to convert to revenue and cash as deliveries normalize, while maintaining alignment between production and sales cadence. Our focus is on disciplined execution — driving structural cost improvements, managing capital efficiently, and improving operating leverage as we scale,” Lucid CFO Taoufiq Boussaid said in a statement.

The comments came as the company reported its first-quarter results that were in line with preliminary results released by the company a month ago, but still significantly missed Wall Street’s expectations.

Here’s how the company performed in the first quarter compared with average estimates compiled by LSEG:

  • Loss per share: $3.46 vs. a loss of $2.64 expected
  • Revenue: $282.5 million vs. $440.4 million expected

The company’s revenue increased roughly 20% year-over-year but was far lower than the 87.4% jump analysts were expecting, according to LSEG.

Lucid produced 5,500 vehicles and delivered 3,093 vehicles in the first quarter of 2026.

Advertisement

The all-electric vehicle maker said a seat supplier issue “significantly affected” deliveries of its crucial Lucid Gravity SUV during the quarter.

Several other automakers have said high gas prices caused by the war in Iran have led to increased interest in all-electric vehicles following a dearth in demand after the Trump administration ended consumer incentives last year of up to $7,500 for the purchase of an EV.

Lucid reported a 144% increase in North America order intake from February to March.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Advertisement
Continue Reading

Business

Jefferies lowers Shopify stock price target to $140 on deceleration concerns

Published

on


Jefferies lowers Shopify stock price target to $140 on deceleration concerns

Continue Reading

Business

US FDA blocked Covid, shingles vaccine safety studies, NYT reports

Published

on

US FDA blocked Covid, shingles vaccine safety studies, NYT reports


US FDA blocked Covid, shingles vaccine safety studies, NYT reports

Continue Reading

Business

Gibson Energy Inc. (GEI:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-05-04 Earnings Summary

EPS of $0.31 beats by $0.03

Gibson Energy Inc. (GEI:CA) Shareholder/Analyst Call May 5, 2026 12:00 PM EDT

Company Participants

James Estey
Nathalie Wyman
Tara Hingley
Riley Hicks – Senior VP & CFO
Colin Gair
Jon Ozirny – VP of Legal & General Counsel
Cody Johnson
Darcy Smith
Chris Garcia
Curtis Philippon – CEO, President & Non-Independent Director

Advertisement

Presentation

James Estey

Okay. We’re going to start early. Good morning, and welcome to the Annual Shareholder Meeting of Gibson Energy. My name is Jim Estey, and I am the Chairman of Gibson Board. And in accordance with the bylaws of the company, I will act as chair of the meeting. Given the importance of safety within Gibson, and our culture, we will start today this meeting with a safety moment from Nathalie Wyman. That will be followed by a land acknowledgment from Tara Hingley and an introduction of the directors and officers who have joined us today. Following completion of these preliminary matters, we will then move into the formal part of the meeting during which you, our shareholders or duly appointed proxyholders will vote on the 3 matters set forth in the management information circular.

Finally, our President and CEO, Curtis Philippon, will provide a company update, which will be followed by question-and-answer period, which you, shareholders and proxyholders are invited to ask questions of the directors and the executive management. At the conclusion of our program, the directors and officers and senior management will be available in the room to answer further questions you may have. I will now call on Nathalie to provide a safety moment.

Advertisement

Nathalie Wyman

Thank you, Mr. Chair. As we begin today, I would like to take a moment to acknowledge that Canadian Mental Health Week began yesterday and continues until Sunday, May 10. This year, Mental Health Week recognizes the role we all play in supporting mental health through connection. At Gibson, Mission Zero is

Advertisement
Continue Reading

Business

BofA raises Pfizer stock price target on first-quarter beat

Published

on


BofA raises Pfizer stock price target on first-quarter beat

Continue Reading

Business

ideaForge Technology bulk deal: BNP Paribas buys Rs 39 crore worth shares in this multibagger

Published

on

ideaForge Technology bulk deal: BNP Paribas buys Rs 39 crore worth shares in this multibagger
Shares of ideaForge Technology Limited witnessed significant bulk deal activity on Tuesday, with multiple institutional investors picking up stakes in the company. Leading the transactions, BNP Paribas, through its affiliate BNP Paribas Financial Markets, bought over 5 lakh shares worth approximately Rs 39 crore at Rs 783.29 apiece.

In addition to BNP Paribas, several other investors were active on the buy side. QE Securities LLP acquired 3.4 lakh shares at Rs 779.23 per share, while NK Securities Research Private Limited picked up a similar quantity at Rs 777.94 per share, translating into deals worth around Rs 26 crore. HRTI Private Limited purchased 4.55 lakh shares at Rs 776.98 apiece, and Junomoneta Finsol Private Limited bought 3.49 lakh shares at Rs 780.2 per share.

The bulk deals were executed within a narrow price band of Rs 776 – Rs 783 per share, indicating strong demand for the stock at current levels. The concentrated buying activity highlights growing investor interest in the company, particularly amid increasing focus on defence and drone-related businesses.

Following the bulk deal activity, the stock saw strong traction in the market, reflecting positive sentiment around the counter.

Advertisement

Ideaforge Technology shares ended at Rs 804.10, up by Rs 73.10 or 10% over the Monday closing price.


Shares of ideaForge have given multibagger returns of 111% over a one-year period compared to negative 1% returns by Nifty and negative 4% by the BSE Sensex.
The stock is currently trading above its 50-day and 200-day simple moving average (SMA) of Rs 457 and Rs 468, respectively, according to Trendlyne data.Also read: Adani Ports, Tata Motors and Siemens Energy witness block deal action on Monday

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)

Continue Reading

Trending

Copyright © 2025